iridium radioisotopes has been researched along with Mucositis, Oral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, JP; Dinshaw, K; Gupta, T; Laskar, SG; Malde, R | 1 |
| Dische, S; Goodchild, K; Hoskin, P; Pigott, K; Powell, M; Saunders, M | 1 |
| Henk, JM | 1 |
3 other study(ies) available for iridium radioisotopes and Mucositis, Oral
| Article | Year |
|---|---|
High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study.
Topics: Antineoplastic Agents; Brachytherapy; Cisplatin; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Mucosa; Nasopharyngeal Neoplasms; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Stomatitis; Treatment Outcome | 2005 |
A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas.
Topics: Adult; Aged; Brachytherapy; Cesium Radioisotopes; Dose Fractionation, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Life Tables; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Stomatitis; Survival Rate; Time Factors | 1999 |
Treatment of oral cancer by interstitial irradiation using iridium-192.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Stomatitis; Survival Rate; Tongue Diseases; Treatment Outcome; Ulcer | 1992 |